CPC A61K 31/7034 (2013.01) [A61K 9/0053 (2013.01); A61K 9/12 (2013.01); A61K 31/05 (2013.01); A61K 31/353 (2013.01); A61K 33/06 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61P 31/14 (2018.01)] | 8 Claims |
1. A method of using a medicament against a novel coronavirus SARS-COV-2, wherein the method comprises:
preparing a medicament comprising tannic acid and zinc gluconate, wherein a mass ratio of the tannic acid to the zinc gluconate is 1:1; and
administering the medicament to a patient infected with the novel coronavirus SARS-CoV-2.
|